Mc2 Drug Patent Portfolio
Mc2 owns 1 orange book drug protected by 3 US patents Given below is the list of Mc2's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11638711 | NULL | 18 Mar, 2039 | Active |
| US11696919 | Topical composition | 18 Mar, 2039 | Active |
| US10265265 | Topical composition | 27 Sep, 2027 | Active |
Latest Legal Activities on Mc2's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mc2.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent eCofC Notification | 19 Mar, 2024 | US11638711 |
|
Email Notification
Critical
| 19 Mar, 2024 | US11638711 |
| Mail Patent eCofC Notification | 19 Mar, 2024 | US11696919 |
| Recordation of Patent eCertificate of Correction | 19 Mar, 2024 | US11638711 |
| Recordation of Patent eCertificate of Correction | 19 Mar, 2024 | US11696919 |
| Patent eCofC Notification | 19 Mar, 2024 | US11696919 |
|
Email Notification
Critical
| 19 Mar, 2024 | US11696919 |
| Mail Patent eCofC Notification | 19 Mar, 2024 | US11638711 |
| Mail Certificate of Correction Memo | 28 Feb, 2024 | US11638711 |
| Post Issue Communication - Certificate of Correction | 28 Feb, 2024 | US11638711 |
| Mail Certificate of Correction Memo | 28 Feb, 2024 | US11696919 |
| Post Issue Communication - Certificate of Correction | 28 Feb, 2024 | US11696919 |
| Certificate of Correction Memo | 26 Feb, 2024 | US11638711 |
| Certificate of Correction Memo | 26 Feb, 2024 | US11696919 |
| Mail Patent eGrant Notification | 11 Jul, 2023 | US11638711 |
Mc2's Family Patents
Mc2 drugs have patent protection in a total of 14 countries. It's US patent count contributes only to 15.8% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Mc2 Drug List
Given below is the complete list of Mc2's drugs and the patents protecting them.
1. Wynzora
Wynzora is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11638711 | NULL |
18 Mar, 2039
(13 years from now)
| Active |
| US11696919 | Topical composition |
18 Mar, 2039
(13 years from now)
| Active |
| US10265265 | Topical composition |
27 Sep, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Wynzora's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List